FDA Adverse Event Injury Summary report: N

NA

MDR report key: 22668564 · Received July 30, 2025

Report

Report Number
3006630150-2025-05984
Event Type
Injury
Date Received
July 30, 2025
Date of Event
January 1, 2025
Report Date
February 25, 2026
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
Product Code
NHL
UDI-DI
08714729820765
PMA / PMN Number
P150031
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

BLOCK B3: APPROXIMATED BASED ON THE DATE THE MANUFACTURER BECAME AWARE OF THE EVENT. ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENT INVOLVED IN THE EVENT: PRODUCT FAMILY: DBS-EXTENSION. UPN: M365NM3138550. MODEL: NM-3138-55. SERIAL: (B)(6). BATCH: 7104456. UDI: (B)(4).

Additional Manufacturer Narrative · 0

CORRECTION TO INITIAL REPORT IN SECTION: H11. BLOCK B3: APPROXIMATED BASED ON THE DATE THE MANUFACTURER BECAME AWARE OF THE EVENT. BLOCK D.2B; ADDITIONAL APPLICABLE PRODUCT CODES: MHY AND PJS. ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENT INVOLVED IN THE EVENT: PRODUCT FAMILY: DBS-EXTENSION UPN: M365NM3138550, MODEL: NM-3138-55, SERIAL: (B)(6), BATCH: 7104456, UDI: (B)(4). PRODUCT FAMILY: DBS-IPG-R-MRI UPN: M365DB12160, MODEL: DB-1216, SERIAL: (B)(6), BATCH: 546826, UDI: (B)(4).

Additional Manufacturer Narrative · 0

BLOCK B3: APPROXIMATED BASED ON THE DATE THE MANUFACTURER BECAME AWARE OF THE EVENT. ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENT INVOLVED IN THE EVENT: PRODUCT FAMILY: DBS-EXTENSION. UPN: M365NM3138550. MODEL: NM-3138-55. SERIAL: (B)(6). BATCH: 7104456. UDI: (B)(4). PRODUCT FAMILY: DBS-IPG-R-MRI. UPN: M365DB12160. MODEL: DB-1216. SERIAL: UNK. BATCH: UNK. UDI: UNK.

Additional Manufacturer Narrative · 0

BLOCK B3: APPROXIMATED BASED ON THE DATE THE MANUFACTURER BECAME AWARE OF THE EVENT. ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENT INVOLVED IN THE EVENT: PRODUCT FAMILY: DBS-EXTENSION. UPN: M365NM3138550. MODEL: NM-3138-55. SERIAL: (B)(6). BATCH: (B)(6). UDI: (B)(4).

Description of Event or Problem · 0

IT WAS REPORTED THAT A PATIENT IMPLANTED WITH A DEEP BRAIN STIMULATION (DBS) SYSTEM EXPERIENCED POST-OPERATIVE HEALING COMPLICATIONS, INCLUDING TISSUE EROSION AT THE INCISION SITE LOCATED BEHIND THE LEFT EAR. THE PATIENT WAS TREATED WITH ANTIBIOTICS. A REVISION PROCEDURE HAS BEEN PLANNED, AND THE EVENT REMAINS ONGOING AND UNDER CLINICAL ASSESSMENT.

Description of Event or Problem · 0

IT WAS REPORTED THAT A PATIENT IMPLANTED WITH A DEEP BRAIN STIMULATION (DBS) SYSTEM EXPERIENCED POST-OPERATIVE HEALING COMPLICATIONS, INCLUDING TISSUE EROSION AT THE INCISION SITE LOCATED BEHIND THE LEFT EAR. THE PATIENT WAS TREATED WITH ANTIBIOTICS. A REVISION PROCEDURE HAS BEEN PLANNED, AND THE EVENT REMAINS ONGOING AND UNDER CLINICAL ASSESSMENT. ADDITIONAL INFORMATION WAS RECEIVED THAT THE PATIENT PRESENTED WITH THE EXTENSION PROTRUDING FROM THE SKIN. THE PATIENT THEN UNDERWENT AN EXPLANT PROCEDURE WHEREIN THE LEFT EXTENSION AND ASSOCIATED IMPLANTABLE PULSE GENERATOR (IPG) WERE EXPLANTED. A NEW EXTENSION WAS IMPLANTED AND CONNECTED TO AN EXISTING IPG. ADDITIONAL INFORMATION WAS RECEIVED THAT THE PATIENT IS HEALING.

Description of Event or Problem · 0

IT WAS REPORTED THAT A PATIENT IMPLANTED WITH A DEEP BRAIN STIMULATION (DBS) SYSTEM EXPERIENCED POST-OPERATIVE HEALING COMPLICATIONS, INCLUDING TISSUE EROSION AT THE INCISION SITE LOCATED BEHIND THE LEFT EAR. THE PATIENT WAS TREATED WITH ANTIBIOTICS. A REVISION PROCEDURE HAS BEEN PLANNED, AND THE EVENT REMAINS ONGOING AND UNDER CLINICAL ASSESSMENT. ADDITIONAL INFORMATION WAS RECEIVED THAT THE PATIENT PRESENTED WITH THE EXTENSION PROTRUDING FROM THE SKIN. THE PATIENT THEN UNDERWENT AN EXPLANT PROCEDURE WHEREIN THE LEFT EXTENSION AND ASSOCIATED IMPLANTABLE PULSE GENERATOR (IPG) WERE EXPLANTED. A NEW EXTENSION WAS IMPLANTED AND CONNECTED TO AN EXISTING IPG.

Description of Event or Problem · 0

IT WAS REPORTED THAT A PATIENT IMPLANTED WITH A DEEP BRAIN STIMULATION (DBS) SYSTEM EXPERIENCED POST-OPERATIVE HEALING COMPLICATIONS, INCLUDING TISSUE EROSION AT THE INCISION SITE LOCATED BEHIND THE LEFT EAR. THE PATIENT WAS TREATED WITH ANTIBIOTICS. A REVISION PROCEDURE HAS BEEN PLANNED, AND THE EVENT REMAINS ONGOING AND UNDER CLINICAL ASSESSMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
612146 NA STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS NHL BOSTON SCIENTIFIC NEUROMODULATION CORPORATION NM-3138-55 7090324 08714729820765

Patients

Seq Age Sex Outcome Treatment
1 68 YR Male Required Intervention